Publication

Treatment of neonatal hyperbilirubinemia: Phototherapy and beyond

van der Schoor, L., 2019, [Groningen]: Rijksuniversiteit Groningen. 265 p.

Research output: ThesisThesis fully internal (DIV)

Copy link to clipboard

Documents

  • Title and contents

    Final publisher's version, 318 KB, PDF document

  • Chapter 1

    Final publisher's version, 919 KB, PDF document

  • Chapter 2

    Final publisher's version, 948 KB, PDF document

  • Chapter 3

    Final publisher's version, 866 KB, PDF document

  • Chapter 4

    Final publisher's version, 1.44 MB, PDF document

  • Chapter 5

    Final publisher's version, 660 KB, PDF document

  • Chapter 6

    Final publisher's version, 0.98 MB, PDF document

    Embargo ends: 23/09/2021

    Request copy

  • Chapter 7

    Final publisher's version, 630 KB, PDF document

  • Appendices

    Final publisher's version, 366 KB, PDF document

  • Complete thesis

    Final publisher's version, 3.82 MB, PDF document

    Embargo ends: 23/09/2021

    Request copy

  • Propositions

    Final publisher's version, 159 KB, PDF document

DOI

  • Lori van der Schoor
Neonatal jaundice, characterized by a yellow colorization of the skin, mucosa and sclerae, is a common disease in newborn infants. Especially in preterm infants it occurs frequently; up to 80% experiences a certain level of jaundice. The yellow colorization is caused by elevated levels of the yellow pigment bilirubin, leading to the name hyperbilirubinemia. Bilirubin is a breakdown product of heme in red blood cells. Premature newborns have a temporary high erythrocyte turnover during the first days of life, which causes a higher bilirubin production. When hyperbilirubinemia is severe, bilirubin can deposit in the brain (especially in the so-called basal nuclei), where it can cause damage. This damage can cause a variety of problems described as kernicterus spectrum disorders (KSD). The KSD can include irreversible cerebral palsy (spasticity) and/or hearing and sight problems. Severe untreated hyperbilirubinemia has even been described to cause death. In order to prevent this neurological damage, it is essential to timely diagnose and treat neonatal hyperbilirubinemia. This thesis describes studies on treatment options of this disease, using both animal models and preterm infants.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
Supervisors/Advisors
Award date23-Sep-2019
Place of Publication[Groningen]
Publisher
Print ISBNs978-94-6375-516-0
Publication statusPublished - 2019

Download statistics

No data available

ID: 98066613